Financing ·
Integra LifeSciences prices $450M of 9.5% senior secured notes due 2033
IARTIntegra Lifesciences Holdings Corp
Integra LifeSciences Holdings Corporation priced $450 million aggregate principal amount of 9.500% senior secured notes due 2033 in a private placement. The notes are general senior secured obligations guaranteed by wholly-owned domestic subsidiaries and are expected to close on or about October 19, 2026. Proceeds will be used to refinance existing credit facilities and pay related fees as part of a broader refinancing transaction. Management anticipates the effective interest rate will increase near the high end of the previously communicated 100-200 basis points range. Integra LifeSciences is a global medical technology leader focused on neurosurgery and tissue reconstruction.